BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
5.22
-0.08 (-1.51%)
Sep 17, 2025, 3:58 PM EDT
BioStem Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2017 | 2012 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '17 Dec 31, 2017 | 2012 - 2016 |
| 307.26 | 301.83 | 16.69 | 6.88 | 4.34 | 0.31 | Upgrade | |
Revenue Growth (YoY) | 133.77% | 1708.93% | 142.69% | 58.38% | 1284.88% | -48.38% | Upgrade |
Cost of Revenue | 9.31 | 13.75 | 1.26 | 0.88 | 1.47 | 0.15 | Upgrade |
Gross Profit | 297.94 | 288.08 | 15.42 | 5.99 | 2.87 | 0.16 | Upgrade |
Selling, General & Admin | 269.18 | 254.75 | 21.91 | 10.21 | 4.07 | 4.77 | Upgrade |
Research & Development | 5.4 | 1.91 | 0.34 | 0.22 | 0.12 | - | Upgrade |
Operating Expenses | 274.81 | 256.88 | 22.48 | 10.67 | 4.47 | 4.77 | Upgrade |
Operating Income | 23.14 | 31.2 | -7.06 | -4.68 | -1.61 | -4.6 | Upgrade |
Interest Expense | -0.2 | -0.59 | -0.7 | -0.47 | -0.53 | -0.03 | Upgrade |
Other Non Operating Income (Expenses) | 0 | - | -0 | 0 | 0.03 | -0.02 | Upgrade |
EBT Excluding Unusual Items | 23.03 | 30.61 | -7.76 | -5.15 | -2.1 | -4.66 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.03 | 0 | Upgrade |
Asset Writedown | - | - | - | - | - | -0.15 | Upgrade |
Legal Settlements | - | - | -0.72 | - | - | - | Upgrade |
Other Unusual Items | - | - | - | -2.08 | 0.66 | - | Upgrade |
Pretax Income | 23.03 | 30.61 | -8.48 | -7.23 | -1.41 | -4.81 | Upgrade |
Income Tax Expense | -3.23 | -1.27 | - | - | - | - | Upgrade |
Earnings From Continuing Operations | 26.26 | 31.88 | -8.48 | -7.23 | -1.41 | -4.81 | Upgrade |
Minority Interest in Earnings | - | - | - | 0.04 | -0.03 | 0.02 | Upgrade |
Net Income | 26.26 | 31.88 | -8.48 | -7.19 | -1.45 | -4.79 | Upgrade |
Net Income to Common | 26.26 | 31.88 | -8.48 | -7.19 | -1.45 | -4.79 | Upgrade |
Shares Outstanding (Basic) | 17 | 16 | 14 | 11 | 12 | 5 | Upgrade |
Shares Outstanding (Diluted) | 23 | 22 | 14 | 11 | 12 | 5 | Upgrade |
Shares Change (YoY) | 31.79% | 58.30% | 20.18% | -2.40% | 130.37% | 43.86% | Upgrade |
EPS (Basic) | 1.59 | 1.95 | -0.62 | -0.63 | -0.12 | -0.94 | Upgrade |
EPS (Diluted) | 1.14 | 1.47 | -0.62 | -0.63 | -0.12 | -0.94 | Upgrade |
Free Cash Flow | - | - | -3.6 | 0.06 | -0.15 | -1.79 | Upgrade |
Free Cash Flow Per Share | - | - | -0.26 | 0.01 | -0.01 | -0.35 | Upgrade |
Gross Margin | 96.97% | 95.45% | 92.44% | 87.17% | 66.03% | 52.25% | Upgrade |
Operating Margin | 7.53% | 10.34% | -42.30% | -68.09% | -36.99% | -1468.50% | Upgrade |
Profit Margin | 8.55% | 10.56% | -50.84% | -104.62% | -33.30% | -1529.17% | Upgrade |
Free Cash Flow Margin | - | - | -21.60% | 0.87% | -3.51% | -572.41% | Upgrade |
EBITDA | 23.35 | 31.41 | -6.83 | -4.46 | -1.32 | -4.44 | Upgrade |
EBITDA Margin | 7.60% | 10.41% | -40.93% | -64.86% | -30.45% | - | Upgrade |
D&A For EBITDA | 0.22 | 0.21 | 0.23 | 0.22 | 0.28 | 0.16 | Upgrade |
EBIT | 23.14 | 31.2 | -7.06 | -4.68 | -1.61 | -4.6 | Upgrade |
EBIT Margin | 7.53% | 10.34% | -42.30% | -68.09% | -36.99% | - | Upgrade |
Advertising Expenses | - | - | 0.2 | 0.09 | 0.07 | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.